Agile Therapeutics Received A Letter Notifying The Company That It Had Been Granted Until Feb. 16, 2024, To Regain Compliance With The Minimum Stockholders' Equity Requirement For Continued Listing On The Nasdaq Capital Market
Agile Therapeutics Received A Letter Notifying The Company That It Had Been Granted Until Feb. 16, 2024, To Regain Compliance With The Minimum Stockholders' Equity Requirement For Continued Listing On The Nasdaq Capital Market
Agile Therapeutics收到一封信，通知该公司已获准在2024年2月16日之前恢复遵守继续在纳斯达克资本市场上市的最低股东权益要求
Agile Therapeutics Received A Letter Notifying The Company That It Had Been Granted Until Feb. 16, 2024, To Regain Compliance With The Minimum Stockholders' Equity Requirement For Continued Listing On The Nasdaq Capital Market
Agile Therapeutics收到一封信，通知该公司已获准在2024年2月16日之前恢复遵守继续在纳斯达克资本市场上市的最低股东权益要求
资讯热榜
更新时间